A Switch-Over Study of the Safety and Efficacy of ISU302 in Patients With Type 1 Gaucher Disease

A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis

NCT01555580 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.

NCT05211986 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of Galcanezumab in Healthy Participants

NCT02576951 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis

NCT06958939 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Eliglustat on Gaucher Disease Type IIIB

NCT03519646 ·Status: COMPLETED ·Phase: NA

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

NCT07304154 ·Status: RECRUITING ·Phase: PHASE1

A Study of Imlifidase in Patients With Guillain-Barré Syndrome

NCT03943589 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.

NCT05947578 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3016859 in Healthy Volunteers

NCT01545583 ·Status: COMPLETED ·Phase: PHASE1

A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Participants

NCT02570373 ·Status: COMPLETED ·Phase: PHASE1

A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis

NCT06149559 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Anti-Shiga Toxin Hyperimmune Equine Immunoglobulin F(ab')2 Fragment (INM004) in Healthy Volunteers

NCT03388216 ·Status: COMPLETED ·Phase: PHASE1

A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)

NCT05681715 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

NCT03772587 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

NCT07250750 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

NCT02565576 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different Ways

NCT06520514 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of CM310 in Subjects With IgG4-related Disease

NCT05728684 ·Status: UNKNOWN ·Phase: NA

A Study to Assess the Tolerability and Safety of Subcutaneously (SC) Administered Immunoglobulin G (IgG) With Varying Injection Conditions

NCT07025577 ·Status: COMPLETED ·Phase: PHASE1

An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy

NCT01830972 ·Status: COMPLETED ·Phase: PHASE2

Intra-monocyte Imiglucerase Kinetics in Gaucher Disease

NCT01951989 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome

NCT02342184 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

NCT03669588 ·Status: COMPLETED ·Phase: PHASE3

Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome

NCT00004833 ·Status: TERMINATED ·Phase: NA

A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants

NCT04085289 ·Status: COMPLETED ·Phase: PHASE1